Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Meda files for European approval of BioDelivery Sciences' BEMA fentanyl

April 4, 2008

Eisai to resume E-2012 clinical trial in Alzheimer's disease

April 4, 2008

Chronogen patent divulges new treatment alternatives for age-related disorders

April 4, 2008

New antidepressive agents reported in recent Lundbeck and NeuroSearch patents

April 3, 2008

FDA grants orphan drug designation to resveratrol formulation in MELAS syndrome

April 3, 2008

Acadia initiates second phase III trial of pimavanserin for Parkinson's disease psychosis

April 3, 2008

Elite presents update on abuse-resistant pain products

April 3, 2008

Cysteine protease inhibitors reduce beta-amyloid, improve memory in Alzheimer's model

April 2, 2008

New agents for treating neurological disorders disclosed in recent patents

April 2, 2008

Synosia Therapeutics commences phase II rufinamide trial for general anxiety disorder

April 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...